The success of Sildenafil initially drove a boom for pharma, nevertheless recent changes present a complicated outlook for shareholders. Off-patent competitors are eroding earnings, and persistent litigation add https://janarwii109981.bloginwi.com/74996038/viagra-and-big-pharma-a-volatile-bet